RPMI Railpen has funded part of the £84.4m in new capital raised by biotech company Oxford Nanopore Technologies.
The company - which has had several successful capital raises this year - is behind the Covid-19 test, Lampore, which has received regulatory approval in the UK and produces results within 90 minut...
To continue reading this article...
Join Professional Pensions
- Unlimited access to real-time news, analysis and opinion from the industry
- Receive our in-depth monthly magazine in either print or digital format
- Access our Sustainable Investment Hub covering news and opinion from thought leaders in the ESG space
- Receive important and breaking news stories selected by the Editors in our daily newsletter
- Hear from industry experts and other forward-thinking leaders
- Receive a monthly members-only newsletter with exclusive opinion pieces from leading industry experts and a feature from the magazine in advance of its release date
